| | | Phone: | (914) 406-8019 | | Fax: | (914) 406-8090 | | Year Established: | 1999 | | Main Contact: | Emer Leahy, Ph.D., M.B.A, President & CEO | | | | Other Contacts: | Christina Leahy, M.S., VP, Quality Assurance and Vivarium Operations
Alberto Ambesi-Impiombato, M.D., Ph.D., Director, Computational Biology
Mitchell Silverstein, B.A., A.A.S., VP, Facilities and Operations
Mukesh Bansal, Ph.D., VP, Data Science
Steven C. Leiser, Ph.D., Sr. Director Translational EEG
Afshin Ghavami, Ph.D., VP, Research
Sylvie Ramboz, Ph.D., VP, Neurodegenerative Disorders
Ronald E.D. Christopher, BA, FCCA, CA(M), VP, Finance
Taleen Hanania, Ph.D., Senior VP, Behavioral Pharmacology
Mark A. Hofer, M.S., J.D., General Counsel
| | | | Company Description | | PsychoGenics combines expertise in behavioral neurobiology with state-of-the-art technology to produce proprietary, high-throughput behavioral testing platforms that rapidly screens compound libraries for CNS activity. These platforms are being used with PsychoGenics’ established behavioral tests to develop a pipeline of in-house and partnered drug candidates addressing such major CNS disorders as ADHD, anxiety, cognitive impairment, depression, eating disorders, pain, and psychosis/schizophrenia. | |
|
